-
Evaluation of Humoral (HI) & Cell-Mediated Immune (CMI) Responses to Trivalent Influenza Vaccine (TIV) Administered Early after Solid-Organ Transplantation (SOT)
-
Evaluation of Immunocompetence in Tolerant Chimeric Recipients of Hematopoietic Stem Cell/Renal Transplants
-
Evaluation of Low-Dose Rituximab Treatment; the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients
-
Evaluation of Non-Adherence in Patients Undergoing Dialysis, Pre- and Post-Kidney Transplantation: US Transplant Practice Patterns Survey
-
Evaluation of Sexual Functions in Females Receiving Renal Replacement Therapies
-
Everolimus (RAD001) Treatment Effect in Liver Transplantation – A Rational Approach To Quantify the mTOR Effect
-
Everolimus Aggravates Tacrolimus-Induced Pancreatic Injury by Pharmacologic Interaction between Everolimus and Tacrolimus
-
Everolimus Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients: 12-24 Month Data from North America
-
Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial
-
Evidence for Chronic Rejection of the Skin and Adnexal Structures in a Hand Transplant Recipient at Six Years Post Transplant without Significant Graft Vasculopathy
- « Previous Page
- 1
- …
- 55
- 56
- 57
- 58
- 59
- …
- 178
- Next Page »